- Home
- ARBE vs CYBN Comparison
ARBE vs CYBN Comparison
Compare ARBE & CYBN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARBE
- CYBN
- Stock Information
- Founded
- ARBE 2015
- CYBN 2019
- Country
- ARBE Israel
- CYBN Canada
- Employees
- ARBE N/A
- CYBN N/A
- Industry
- ARBE EDP Services
- CYBN Pharmaceuticals and Biotechnology
- Sector
- ARBE Technology
- CYBN Health Care
- Exchange
- ARBE Nasdaq
- CYBN Nasdaq
- Market Cap
- ARBE 203.2M
- CYBN 176.5M
- IPO Year
- ARBE N/A
- CYBN N/A
- Fundamental
- Price
- ARBE $1.34
- CYBN $6.08
- Analyst Decision
- ARBE Buy
- CYBN Strong Buy
- Analyst Count
- ARBE 2
- CYBN 3
- Target Price
- ARBE $1.75
- CYBN $85.00
- AVG Volume (30 Days)
- ARBE 1.1M
- CYBN 625.2K
- Earning Date
- ARBE 08-07-2025
- CYBN 11-12-2025
- Dividend Yield
- ARBE N/A
- CYBN N/A
- EPS Growth
- ARBE N/A
- CYBN N/A
- EPS
- ARBE N/A
- CYBN N/A
- Revenue
- ARBE $536,000.00
- CYBN N/A
- Revenue This Year
- ARBE $301.82
- CYBN N/A
- Revenue Next Year
- ARBE $250.52
- CYBN N/A
- P/E Ratio
- ARBE N/A
- CYBN N/A
- Revenue Growth
- ARBE N/A
- CYBN N/A
- 52 Week Low
- ARBE $0.85
- CYBN $4.81
- 52 Week High
- ARBE $5.09
- CYBN $13.88
- Technical
- Relative Strength Index (RSI)
- ARBE 50.83
- CYBN 38.92
- Support Level
- ARBE $1.27
- CYBN $6.16
- Resistance Level
- ARBE $1.44
- CYBN $6.55
- Average True Range (ATR)
- ARBE 0.08
- CYBN 0.49
- MACD
- ARBE 0.02
- CYBN -0.06
- Stochastic Oscillator
- ARBE 52.00
- CYBN 12.90
About ARBE Arbe Robotics Ltd.
Arbe Robotics Ltd is a provider of 4D Imaging Radar solutions enabling driver-assist systems while paving the way for fully autonomous driving. It is a research and development company in the field of chips for Advanced radar systems, which are mainly intended to be used as Advanced Driver Assistance Systems (ADAS) adapted for autonomous vehicles as well as for non-automotive uses. Its geographical segments include Sweden, China, Germany, Hong Kong, USA, Israel, Switzerland, Italy, and others.
About CYBN Cybin Inc.
Cybin Inc is a biopharmaceutical company involved in creating safe and effective therapeutics for patients to address a multitude of mental health issues. The Company is a clinical-stage neuropsychiatric company focused on advancing therapies, delivery mechanisms, novel compounds, and protocols as potential treatments for various psychiatric and neurological conditions. The Company is developing technologies and delivery systems aimed at improving the pharmacokinetics of its proprietary molecules while retaining the therapeutic benefit. These new molecules and delivery systems are expected to be studied through clinical trials to confirm safety and efficacy.